Global Trends in the Epidemiology and Management of Dyslipidemia

被引：43

作者：

Liu, Tianxiao ^{[1
]}

Zhao, Dong ^{[1
]}

Qi, Yue ^{[1
]}

机构：

[1] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Ctr Clin & Epidemiol Res,Beijing Anzhen Hosp,Key, Minist Educ,Beijing Municipal Key Lab Clin Epidem, Beijing 100029, Peoples R China

来源：

JOURNAL OF CLINICAL MEDICINE | 2022年 / 11卷 / 21期

关键词：

dyslipidemia; epidemiology; guidelines; therapy; management; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; COST-EFFECTIVENESS; LIPID DISORDERS; STATIN THERAPY; GUIDELINES; CHOLESTEROL; PREVALENCE; ADULTS; EZETIMIBE;

D O I：

10.3390/jcm11216377

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Dyslipidemia, especially a circulating non-optimal level of cholesterol, is one of the most important risk factors for atherosclerotic cardiovascular disease (ASCVD), which accounts for the most deaths worldwide. Maintaining a healthy level of blood cholesterol is an important prevention strategy for ASCVD, through lifestyle intervention or cholesterol-lowering therapy. Over the past three decades, the epidemiology and management of dyslipidemia has changed greatly in many countries. Therefore, it is necessary to understand the current epidemiologic features of dyslipidemia and challenges from a global perspective.

引用

页数：13

共 58 条

[1] Dyslipidaemia in the Middle East: Current status and a call for action [J].

Al Rasadi, Khalid ;

Almahmeed, Wael ;

AlHabib, Khalid F. ;

Abifadel, Marianne ;

Farhan, Hasan Ali ;

AlSifri, Saud ;

Jambart, Selim ;

Zubaid, Mohammad ;

Awan, Zuhier ;

Al-Waili, Khalid ;

Barter, Philip .

ATHEROSCLEROSIS, 2016, 252 :182-187

[2]

[Anonymous], GBD RES TOOL

[3] PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021 [J].

Banach, Maciej ;

Burchardt, Pawl ;

Chlebus, Krzysztof ;

Dobrowolski, Piotr ;

Dudek, Dariusz ;

Dyrbus, Krzysztof ;

Gasior, Mariusz ;

Jankowski, Piotr ;

Jozwiak, Jacek ;

Klosiewicz-Latoszek, Longina ;

Kowalska, Irina ;

Malecki, Maciej ;

Prejbisz, Aleksander ;

Rakowski, Michat ;

Rysz, Jacek ;

Solnica, Bogdan ;

Sitkiewicz, Dariusz ;

Sygitowicz, Grazyna ;

Sypniewska, Grazyna ;

Tomasik, Tomasz ;

Windak, Adam ;

Zozulinska-Ziolkiewicz, Dorota ;

Cybulska, Barbara .

ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (06) :1447-1547

[4] Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia [J].

Bhatt, Deepak L. ;

Steg, P. Gabriel ;

Miller, Michael ;

Brinton, Eliot A. ;

Jacobson, Terry A. ;

Ketchum, Steven B. ;

Doyle, Ralph T., Jr. ;

Juliano, Rebecca A. ;

Jiao, Lixia ;

Granowitz, Craig ;

Tardif, Jean-Claude ;

Ballantyne, Christie M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01) :11-22

[5] Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel [J].

Boren, Jan ;

Chapman, M. John ;

Krauss, Ronald M. ;

Packard, Chris J. ;

Bentzon, Jacob F. ;

Binder, Christoph J. ;

Daemen, Mat J. ;

Demer, Linda L. ;

Hegele, Robert A. ;

Nicholls, Stephen J. ;

Nordestgaard, Brge G. ;

Watts, Gerald F. ;

Bruckert, Eric ;

Fazio, Sergio ;

Ference, Brian A. ;

Graham, Ian ;

Horton, Jay D. ;

Landmesser, Ulf ;

Laufs, Ulrich ;

Masana, Luis ;

Pasterkamp, Gerard ;

Raal, Frederick J. ;

Ray, Kausik K. ;

Schunkert, Heribert ;

Taskinen, Marja-Riitta ;

van de Sluis, Bart ;

Wiklund, Olov ;

Tokgozoglu, Lale ;

Catapano, Alberico L. ;

Ginsberg, Henry N. .

EUROPEAN HEART JOURNAL, 2020, 41 (24) :2313-+

[6] Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes [J].

Cannon, Christopher P. ;

Blazing, Michael A. ;

Giugliano, Robert P. ;

McCagg, Amy ;

White, Jennifer A. ;

Theroux, Pierre ;

Darius, Harald ;

Lewis, Basil S. ;

Ophuis, Ton Oude ;

Jukema, J. Wouter ;

De Ferrari, Gaetano M. ;

Ruzyllo, Witold ;

De Lucca, Paul ;

Im, KyungAh ;

Bohula, Erin A. ;

Reist, Craig ;

Wiviott, Stephen D. ;

Tershakovec, Andrew M. ;

Musliner, Thomas A. ;

Braunwald, Eugene ;

Califf, Robert M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) :2387-2397

[7] Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis [J].

Chen, Wei ;

Schilperoort, Maaike ;

Cao, Yihai ;

Shi, Jinjun ;

Tabas, Ira ;

Tao, Wei .

NATURE REVIEWS CARDIOLOGY, 2022, 19 (04) :228-249

[8] Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].

Colhoun, HM ;

Betteridge, DJ ;

Durrington, PN ;

Hitman, GA ;

Neil, HAW ;

Livingstone, SJ ;

Thomason, MJ ;

Mackness, MI ;

Charlton-Menys, V ;

Fuller, JH .

LANCET, 2004, 364 (9435) :685-696

[9] Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel [J].